MicroRNA-145 inhibits tumorigenesis and invasion of cervical cancer stem cells

MicroRNA (miR)-145 has been reported to induce cancer stem cell (CSC) differentiation through down-regulation of the stem cell transcription factors (TFs) that maintain CSC pluripotency. High expression of miR-145 indicates a good prognosis in cancer patients, but its role in cervical cancer stem ce...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International journal of oncology 2017-03, Vol.50 (3), p.853-862
Hauptverfasser: Zhou, Xi, Yue, Yan, Wang, Renxiao, Gong, Baolan, Duan, Zhao
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 862
container_issue 3
container_start_page 853
container_title International journal of oncology
container_volume 50
creator Zhou, Xi
Yue, Yan
Wang, Renxiao
Gong, Baolan
Duan, Zhao
description MicroRNA (miR)-145 has been reported to induce cancer stem cell (CSC) differentiation through down-regulation of the stem cell transcription factors (TFs) that maintain CSC pluripotency. High expression of miR-145 indicates a good prognosis in cancer patients, but its role in cervical cancer stem cells (CCSCs) is not known. We show that expression of miR-145 and core stem cell transcription factors, Sox2, Nanog and Oct4, are associated with the pluripotency of CCSCs, with increased expression of miR-145 after cervical tumorsphere (CT) differentiation. miR-145 overexpression inhibited expression of core TFs, as well as decreasing tumor invasion and colony formation, whereas miR-145 knockdown led to the opposite effects. Injection of adenovirus-miR-145 significantly reduced tumor growth in nude mice. High miR-145 expression predicted a better prognosis compared with that in patients with low miR-145 expression after analyses of The Cancer Genome Atlas (TCGA) data. These results suggest that miR-145 is able to induce CT differentiation through enzymolyzing TFs and might be a therapeutic target for cervical carcinoma.
doi_str_mv 10.3892/ijo.2017.3857
format Article
fullrecord <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_journals_1957649293</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A491157080</galeid><sourcerecordid>A491157080</sourcerecordid><originalsourceid>FETCH-LOGICAL-c524t-949fb1057a86d964c400d5baa6749e3cbff03541fbc3e154a8352cae45d54e843</originalsourceid><addsrcrecordid>eNptkUtLxDAQgIMouq4evUpB8NY1k0fbHJfFF_gA0XNI08TN0jZr0gr-e7P4Bskhk8k3EzIfQkeAZ7QS5Myt_IxgKNOJl1toAqWAnDBCt1OMQeQFo2IP7ce4wphwjmEX7ZEKgNASJuju1ungH-7mOTCeuX7pajfEbBg7H9yz6U10MVN9k65eVXS-z7zNtAmvTqs206pPcRYH06Vk28YDtGNVG83h5z5FTxfnj4ur_Ob-8noxv8k1J2zIBRO2BsxLVRWNKJhmGDe8VqoomTBU19ZiyhnYWlMDnKmKcqKVYbzhzFSMTtHJR9918C-jiYNc-TH06UkJgpcFE0TQH-pZtUa63vohKN25qOWcCQBe4gonavYPlVZjOqd9b6xL-T8Fp78Klka1wzL6dhzSeOJfMP8A04hjDMbKdXCdCm8SsNzYk8me3NiTG3uJP_781Vh3pvmmv3TRd1h3keg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1957649293</pqid></control><display><type>article</type><title>MicroRNA-145 inhibits tumorigenesis and invasion of cervical cancer stem cells</title><source>Spandidos Publications Journals</source><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Zhou, Xi ; Yue, Yan ; Wang, Renxiao ; Gong, Baolan ; Duan, Zhao</creator><creatorcontrib>Zhou, Xi ; Yue, Yan ; Wang, Renxiao ; Gong, Baolan ; Duan, Zhao</creatorcontrib><description>MicroRNA (miR)-145 has been reported to induce cancer stem cell (CSC) differentiation through down-regulation of the stem cell transcription factors (TFs) that maintain CSC pluripotency. High expression of miR-145 indicates a good prognosis in cancer patients, but its role in cervical cancer stem cells (CCSCs) is not known. We show that expression of miR-145 and core stem cell transcription factors, Sox2, Nanog and Oct4, are associated with the pluripotency of CCSCs, with increased expression of miR-145 after cervical tumorsphere (CT) differentiation. miR-145 overexpression inhibited expression of core TFs, as well as decreasing tumor invasion and colony formation, whereas miR-145 knockdown led to the opposite effects. Injection of adenovirus-miR-145 significantly reduced tumor growth in nude mice. High miR-145 expression predicted a better prognosis compared with that in patients with low miR-145 expression after analyses of The Cancer Genome Atlas (TCGA) data. These results suggest that miR-145 is able to induce CT differentiation through enzymolyzing TFs and might be a therapeutic target for cervical carcinoma.</description><identifier>ISSN: 1019-6439</identifier><identifier>EISSN: 1791-2423</identifier><identifier>DOI: 10.3892/ijo.2017.3857</identifier><identifier>PMID: 28112371</identifier><language>eng</language><publisher>Greece: Spandidos Publications</publisher><subject>Adenoviruses ; Adult ; Aged ; Animals ; Cancer therapies ; Carcinogenesis - genetics ; Care and treatment ; Cell Proliferation - genetics ; Cervical cancer ; Cloning ; Development and progression ; Female ; Gene expression ; Gene Knockdown Techniques ; Genetic aspects ; Health aspects ; Humans ; Medical prognosis ; Metastasis ; Mice ; Mice, Nude ; MicroRNA ; MicroRNAs - genetics ; Middle Aged ; Nanog Homeobox Protein - metabolism ; Neoplasm Invasiveness - genetics ; Neoplastic Stem Cells - pathology ; Octamer Transcription Factor-3 - metabolism ; Pluripotent Stem Cells - pathology ; Prognosis ; SOXB1 Transcription Factors - metabolism ; Stem cells ; Transcription factors ; Tumor Cells, Cultured ; Tumors ; Uterine Cervical Neoplasms - genetics ; Uterine Cervical Neoplasms - pathology</subject><ispartof>International journal of oncology, 2017-03, Vol.50 (3), p.853-862</ispartof><rights>COPYRIGHT 2017 Spandidos Publications</rights><rights>Copyright Spandidos Publications UK Ltd. 2017</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c524t-949fb1057a86d964c400d5baa6749e3cbff03541fbc3e154a8352cae45d54e843</citedby><cites>FETCH-LOGICAL-c524t-949fb1057a86d964c400d5baa6749e3cbff03541fbc3e154a8352cae45d54e843</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28112371$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Zhou, Xi</creatorcontrib><creatorcontrib>Yue, Yan</creatorcontrib><creatorcontrib>Wang, Renxiao</creatorcontrib><creatorcontrib>Gong, Baolan</creatorcontrib><creatorcontrib>Duan, Zhao</creatorcontrib><title>MicroRNA-145 inhibits tumorigenesis and invasion of cervical cancer stem cells</title><title>International journal of oncology</title><addtitle>Int J Oncol</addtitle><description>MicroRNA (miR)-145 has been reported to induce cancer stem cell (CSC) differentiation through down-regulation of the stem cell transcription factors (TFs) that maintain CSC pluripotency. High expression of miR-145 indicates a good prognosis in cancer patients, but its role in cervical cancer stem cells (CCSCs) is not known. We show that expression of miR-145 and core stem cell transcription factors, Sox2, Nanog and Oct4, are associated with the pluripotency of CCSCs, with increased expression of miR-145 after cervical tumorsphere (CT) differentiation. miR-145 overexpression inhibited expression of core TFs, as well as decreasing tumor invasion and colony formation, whereas miR-145 knockdown led to the opposite effects. Injection of adenovirus-miR-145 significantly reduced tumor growth in nude mice. High miR-145 expression predicted a better prognosis compared with that in patients with low miR-145 expression after analyses of The Cancer Genome Atlas (TCGA) data. These results suggest that miR-145 is able to induce CT differentiation through enzymolyzing TFs and might be a therapeutic target for cervical carcinoma.</description><subject>Adenoviruses</subject><subject>Adult</subject><subject>Aged</subject><subject>Animals</subject><subject>Cancer therapies</subject><subject>Carcinogenesis - genetics</subject><subject>Care and treatment</subject><subject>Cell Proliferation - genetics</subject><subject>Cervical cancer</subject><subject>Cloning</subject><subject>Development and progression</subject><subject>Female</subject><subject>Gene expression</subject><subject>Gene Knockdown Techniques</subject><subject>Genetic aspects</subject><subject>Health aspects</subject><subject>Humans</subject><subject>Medical prognosis</subject><subject>Metastasis</subject><subject>Mice</subject><subject>Mice, Nude</subject><subject>MicroRNA</subject><subject>MicroRNAs - genetics</subject><subject>Middle Aged</subject><subject>Nanog Homeobox Protein - metabolism</subject><subject>Neoplasm Invasiveness - genetics</subject><subject>Neoplastic Stem Cells - pathology</subject><subject>Octamer Transcription Factor-3 - metabolism</subject><subject>Pluripotent Stem Cells - pathology</subject><subject>Prognosis</subject><subject>SOXB1 Transcription Factors - metabolism</subject><subject>Stem cells</subject><subject>Transcription factors</subject><subject>Tumor Cells, Cultured</subject><subject>Tumors</subject><subject>Uterine Cervical Neoplasms - genetics</subject><subject>Uterine Cervical Neoplasms - pathology</subject><issn>1019-6439</issn><issn>1791-2423</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNptkUtLxDAQgIMouq4evUpB8NY1k0fbHJfFF_gA0XNI08TN0jZr0gr-e7P4Bskhk8k3EzIfQkeAZ7QS5Myt_IxgKNOJl1toAqWAnDBCt1OMQeQFo2IP7ce4wphwjmEX7ZEKgNASJuju1ungH-7mOTCeuX7pajfEbBg7H9yz6U10MVN9k65eVXS-z7zNtAmvTqs206pPcRYH06Vk28YDtGNVG83h5z5FTxfnj4ur_Ob-8noxv8k1J2zIBRO2BsxLVRWNKJhmGDe8VqoomTBU19ZiyhnYWlMDnKmKcqKVYbzhzFSMTtHJR9918C-jiYNc-TH06UkJgpcFE0TQH-pZtUa63vohKN25qOWcCQBe4gonavYPlVZjOqd9b6xL-T8Fp78Klka1wzL6dhzSeOJfMP8A04hjDMbKdXCdCm8SsNzYk8me3NiTG3uJP_781Vh3pvmmv3TRd1h3keg</recordid><startdate>20170301</startdate><enddate>20170301</enddate><creator>Zhou, Xi</creator><creator>Yue, Yan</creator><creator>Wang, Renxiao</creator><creator>Gong, Baolan</creator><creator>Duan, Zhao</creator><general>Spandidos Publications</general><general>Spandidos Publications UK Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AN0</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope></search><sort><creationdate>20170301</creationdate><title>MicroRNA-145 inhibits tumorigenesis and invasion of cervical cancer stem cells</title><author>Zhou, Xi ; Yue, Yan ; Wang, Renxiao ; Gong, Baolan ; Duan, Zhao</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c524t-949fb1057a86d964c400d5baa6749e3cbff03541fbc3e154a8352cae45d54e843</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Adenoviruses</topic><topic>Adult</topic><topic>Aged</topic><topic>Animals</topic><topic>Cancer therapies</topic><topic>Carcinogenesis - genetics</topic><topic>Care and treatment</topic><topic>Cell Proliferation - genetics</topic><topic>Cervical cancer</topic><topic>Cloning</topic><topic>Development and progression</topic><topic>Female</topic><topic>Gene expression</topic><topic>Gene Knockdown Techniques</topic><topic>Genetic aspects</topic><topic>Health aspects</topic><topic>Humans</topic><topic>Medical prognosis</topic><topic>Metastasis</topic><topic>Mice</topic><topic>Mice, Nude</topic><topic>MicroRNA</topic><topic>MicroRNAs - genetics</topic><topic>Middle Aged</topic><topic>Nanog Homeobox Protein - metabolism</topic><topic>Neoplasm Invasiveness - genetics</topic><topic>Neoplastic Stem Cells - pathology</topic><topic>Octamer Transcription Factor-3 - metabolism</topic><topic>Pluripotent Stem Cells - pathology</topic><topic>Prognosis</topic><topic>SOXB1 Transcription Factors - metabolism</topic><topic>Stem cells</topic><topic>Transcription factors</topic><topic>Tumor Cells, Cultured</topic><topic>Tumors</topic><topic>Uterine Cervical Neoplasms - genetics</topic><topic>Uterine Cervical Neoplasms - pathology</topic><toplevel>online_resources</toplevel><creatorcontrib>Zhou, Xi</creatorcontrib><creatorcontrib>Yue, Yan</creatorcontrib><creatorcontrib>Wang, Renxiao</creatorcontrib><creatorcontrib>Gong, Baolan</creatorcontrib><creatorcontrib>Duan, Zhao</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>British Nursing Database</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><jtitle>International journal of oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Zhou, Xi</au><au>Yue, Yan</au><au>Wang, Renxiao</au><au>Gong, Baolan</au><au>Duan, Zhao</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>MicroRNA-145 inhibits tumorigenesis and invasion of cervical cancer stem cells</atitle><jtitle>International journal of oncology</jtitle><addtitle>Int J Oncol</addtitle><date>2017-03-01</date><risdate>2017</risdate><volume>50</volume><issue>3</issue><spage>853</spage><epage>862</epage><pages>853-862</pages><issn>1019-6439</issn><eissn>1791-2423</eissn><abstract>MicroRNA (miR)-145 has been reported to induce cancer stem cell (CSC) differentiation through down-regulation of the stem cell transcription factors (TFs) that maintain CSC pluripotency. High expression of miR-145 indicates a good prognosis in cancer patients, but its role in cervical cancer stem cells (CCSCs) is not known. We show that expression of miR-145 and core stem cell transcription factors, Sox2, Nanog and Oct4, are associated with the pluripotency of CCSCs, with increased expression of miR-145 after cervical tumorsphere (CT) differentiation. miR-145 overexpression inhibited expression of core TFs, as well as decreasing tumor invasion and colony formation, whereas miR-145 knockdown led to the opposite effects. Injection of adenovirus-miR-145 significantly reduced tumor growth in nude mice. High miR-145 expression predicted a better prognosis compared with that in patients with low miR-145 expression after analyses of The Cancer Genome Atlas (TCGA) data. These results suggest that miR-145 is able to induce CT differentiation through enzymolyzing TFs and might be a therapeutic target for cervical carcinoma.</abstract><cop>Greece</cop><pub>Spandidos Publications</pub><pmid>28112371</pmid><doi>10.3892/ijo.2017.3857</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1019-6439
ispartof International journal of oncology, 2017-03, Vol.50 (3), p.853-862
issn 1019-6439
1791-2423
language eng
recordid cdi_proquest_journals_1957649293
source Spandidos Publications Journals; MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection
subjects Adenoviruses
Adult
Aged
Animals
Cancer therapies
Carcinogenesis - genetics
Care and treatment
Cell Proliferation - genetics
Cervical cancer
Cloning
Development and progression
Female
Gene expression
Gene Knockdown Techniques
Genetic aspects
Health aspects
Humans
Medical prognosis
Metastasis
Mice
Mice, Nude
MicroRNA
MicroRNAs - genetics
Middle Aged
Nanog Homeobox Protein - metabolism
Neoplasm Invasiveness - genetics
Neoplastic Stem Cells - pathology
Octamer Transcription Factor-3 - metabolism
Pluripotent Stem Cells - pathology
Prognosis
SOXB1 Transcription Factors - metabolism
Stem cells
Transcription factors
Tumor Cells, Cultured
Tumors
Uterine Cervical Neoplasms - genetics
Uterine Cervical Neoplasms - pathology
title MicroRNA-145 inhibits tumorigenesis and invasion of cervical cancer stem cells
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-06T09%3A43%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=MicroRNA-145%20inhibits%20tumorigenesis%20and%20invasion%20of%20cervical%20cancer%20stem%20cells&rft.jtitle=International%20journal%20of%20oncology&rft.au=Zhou,%20Xi&rft.date=2017-03-01&rft.volume=50&rft.issue=3&rft.spage=853&rft.epage=862&rft.pages=853-862&rft.issn=1019-6439&rft.eissn=1791-2423&rft_id=info:doi/10.3892/ijo.2017.3857&rft_dat=%3Cgale_proqu%3EA491157080%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1957649293&rft_id=info:pmid/28112371&rft_galeid=A491157080&rfr_iscdi=true